AccessHope’s Executive Medical Director, Jack West, MD, shares his perspective on lung cancer treatment advancements and the recent results of the ADAURA trial in a Viewpoint for JAMA Oncology. In this piece, Dr. West emphasizes the importance of the knowledge uncovered, comments on the benefits and pitfalls of the trial, and highlights the continued work that must be done by the oncological community to optimize patient outcomes.
Read Full Article Here